Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Diabetes & Endocrinology Unpaywall

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

The Lancet Diabetes & EndocrinologyJul 1, 2019

 
/lp/unpaywall/adjunctive-liraglutide-treatment-in-patients-with-persistent-or-d1stXLOfcd

References (40)

Publisher
Unpaywall
ISSN
2213-8587
DOI
10.1016/s2213-8587(19)30157-3
Publisher site
See Article on Publisher Site

Abstract

Journal

The Lancet Diabetes & EndocrinologyUnpaywall

Published: Jul 1, 2019

There are no references for this article.